NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,084 filers reported holding NOVARTIS A G in Q4 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $258,000 | -17.3% | 3,133 | -4.9% | 0.28% | +11.2% |
| Q4 2019 | $312,000 | +7.6% | 3,296 | -1.2% | 0.25% | +4.6% |
| Q3 2019 | $290,000 | -4.6% | 3,335 | +0.3% | 0.24% | -3.6% |
| Q2 2019 | $304,000 | -11.6% | 3,325 | -7.1% | 0.25% | -16.8% |
| Q1 2019 | $344,000 | +13.5% | 3,579 | +1.4% | 0.30% | -0.3% |
| Q4 2018 | $303,000 | +8.2% | 3,529 | +8.5% | 0.30% | +31.7% |
| Q3 2018 | $280,000 | +13.8% | 3,252 | 0.0% | 0.23% | +49.3% |
| Q2 2018 | $246,000 | -48.4% | 3,252 | -44.9% | 0.15% | -42.2% |
| Q1 2018 | $477,000 | +7.4% | 5,898 | +11.5% | 0.26% | +1.9% |
| Q4 2017 | $444,000 | -2.2% | 5,290 | 0.0% | 0.26% | +0.4% |
| Q3 2017 | $454,000 | +2.7% | 5,290 | 0.0% | 0.26% | +8.0% |
| Q2 2017 | $442,000 | +12.5% | 5,290 | 0.0% | 0.24% | +8.7% |
| Q1 2017 | $393,000 | +2.1% | 5,290 | 0.0% | 0.22% | -6.8% |
| Q4 2016 | $385,000 | +13.2% | 5,290 | +23.0% | 0.24% | +2.2% |
| Q3 2016 | $340,000 | – | 4,300 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |